Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 2, 2021

Primary Completion Date

April 13, 2021

Study Completion Date

April 13, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

REDD-CAT

After obtaining informed consent from a participant and gathering baseline data, the study RA will send a flag in the EMR to notify the nurse care manager that a patient has enrolled in the REDD-CAT pilot. The nurse care manager will then incorporate the administration of the REDD-CAT to the patient as part of standard care discharge planning. He or she will utilize the REDD-CAT results report as a guideline for generating appropriate referrals to address unmet social needs identified.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Boston Medical Center

OTHER